Literature DB >> 30061199

Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPα.

Hong Guo1, Theresa Barberi1, Rahul Suresh1, Alan D Friedman2.   

Abstract

The C/EBPα transcription factor is required for myelopoiesis, with prior observations suggesting additional contributions to B lymphopoiesis. Cebpa expression is evident in common lymphoid progenitor (CLP) and preproB cells but is absent in proB and preB cells. We previously observed that marrow lacking the Cebpa +37 kb enhancer is impaired in producing B cells upon competitive transplantation. Additionally, a Cebpa enhancer/promoter-hCD4 transgene is expressed in B/myeloid CFU. Extending these findings, pan-hematopoietic murine Cebpa enhancer deletion using Mx1-Cre leads to expanded CLP, fewer preproB cells, markedly reduced proB and preB cells, and reduced mature B cells, without affecting T cell numbers. In contrast, enhancer deletion at the proB stage using Mb1-Cre does not impair B cell maturation. Further evaluation of CLP reveals that the Cebpa transgene is expressed almost exclusively in Flt3+ multipotent CLP versus B cell-restricted Flt3- CLP. In vitro, hCD4+ preproB cells produce both B and myeloid cells, whereas hCD4- preproB cells only produce B cells. Additionally, a subset of hCD4- preproB cells express high levels of RAG1-GFP, as seen also in proB cells. Global gene expression analysis indicates that hCD4+ preproB cells express proliferative pathways, whereas B cell development and signal transduction pathways predominate in hCD4- preproB cells. Consistent with these changes, Cebpa enhancer-deleted preproB cells downmodulate cell cycle pathways while upregulating B cell signaling pathways. Collectively, these findings indicate that C/EBPα is required for Flt3+ CLP maturation into preproB cells and then for proliferative Cebpaint B/myeloid preproB cells to progress to Cebpalo B cell-restricted preproB cells and finally to Cebpaneg proB cells.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30061199      PMCID: PMC6125169          DOI: 10.4049/jimmunol.1800244

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages.

Authors:  Holger Karsunky; Matthew A Inlay; Thomas Serwold; Deepta Bhattacharya; Irving L Weissman
Journal:  Blood       Date:  2008-04-18       Impact factor: 22.113

2.  Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development.

Authors:  Matthew A Inlay; Deepta Bhattacharya; Debashis Sahoo; Thomas Serwold; Jun Seita; Holger Karsunky; Sylvia K Plevritis; David L Dill; Irving L Weissman
Journal:  Genes Dev       Date:  2009-10-15       Impact factor: 11.361

3.  Expression of B220 on activated T cell blasts precedes apoptosis.

Authors:  T Renno; A Attinger; D Rimoldi; M Hahne; J Tschopp; H R MacDonald
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

4.  The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.

Authors:  Ari Itoh-Nakadai; Reina Hikota; Akihiko Muto; Kohei Kometani; Miki Watanabe-Matsui; Yuki Sato; Masahiro Kobayashi; Atsushi Nakamura; Yuichi Miura; Yoko Yano; Satoshi Tashiro; Jiying Sun; Tomokatsu Ikawa; Kyoko Ochiai; Tomohiro Kurosaki; Kazuhiko Igarashi
Journal:  Nat Immunol       Date:  2014-10-26       Impact factor: 25.606

Review 5.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

6.  CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.

Authors:  Ido Paz-Priel; Dong Hong Cai; Dehua Wang; Jeanne Kowalski; Amanda Blackford; Huaitian Liu; Caroline A Heckman; Adrian F Gombart; H Phillip Koeffler; Linda M Boxer; Alan D Friedman
Journal:  Mol Cancer Res       Date:  2005-10       Impact factor: 5.852

7.  Failure of B-cell differentiation in mice lacking the transcription factor EBF.

Authors:  H Lin; R Grosschedl
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

8.  A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.

Authors:  Yin C Lin; Suchit Jhunjhunwala; Christopher Benner; Sven Heinz; Eva Welinder; Robert Mansson; Mikael Sigvardsson; James Hagman; Celso A Espinoza; Janusz Dutkowski; Trey Ideker; Christopher K Glass; Cornelis Murre
Journal:  Nat Immunol       Date:  2010-06-13       Impact factor: 25.606

9.  Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice.

Authors:  Karin von Wnuck Lipinski; Katherine Sattler; Susann Peters; Sarah Weske; Petra Keul; Hannes Klump; Gerd Heusch; Joachim R Göthert; Bodo Levkau
Journal:  J Immunol       Date:  2016-01-22       Impact factor: 5.422

10.  In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.

Authors:  Hong Guo; Stacy Cooper; Alan D Friedman
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more
  6 in total

1.  The genomic landscape of pediatric acute lymphoblastic leukemia.

Authors:  Samuel W Brady; Kathryn G Roberts; Zhaohui Gu; Lei Shi; Stanley Pounds; Deqing Pei; Cheng Cheng; Yunfeng Dai; Meenakshi Devidas; Chunxu Qu; Ashley N Hill; Debbie Payne-Turner; Xiaotu Ma; Ilaria Iacobucci; Pradyuamna Baviskar; Lei Wei; Sasi Arunachalam; Kohei Hagiwara; Yanling Liu; Diane A Flasch; Yu Liu; Matthew Parker; Xiaolong Chen; Abdelrahman H Elsayed; Omkar Pathak; Yongjin Li; Yiping Fan; J Robert Michael; Michael Rusch; Mark R Wilkinson; Scott Foy; Dale J Hedges; Scott Newman; Xin Zhou; Jian Wang; Colleen Reilly; Edgar Sioson; Stephen V Rice; Victor Pastor Loyola; Gang Wu; Evadnie Rampersaud; Shalini C Reshmi; Julie Gastier-Foster; Jaime M Guidry Auvil; Patee Gesuwan; Malcolm A Smith; Naomi Winick; Andrew J Carroll; Nyla A Heerema; Richard C Harvey; Cheryl L Willman; Eric Larsen; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Stuart S Winter; Michael J Burke; Wanda Salzer; Kimberly P Dunsmore; Anne L Angiolillo; Kristine R Crews; James R Downing; Sima Jeha; Ching-Hon Pui; William E Evans; Jun J Yang; Mary V Relling; Daniela S Gerhard; Mignon L Loh; Stephen P Hunger; Jinghui Zhang; Charles G Mullighan
Journal:  Nat Genet       Date:  2022-09-01       Impact factor: 41.307

2.  Dynamical modeling predicts an inflammation-inducible CXCR7+ B cell precursor with potential implications in lymphoid blockage pathologies.

Authors:  Jennifer Enciso; Luis Mendoza; Elena R Álvarez-Buylla; Rosana Pelayo
Journal:  PeerJ       Date:  2020-09-29       Impact factor: 2.984

3.  Comparative Transcriptomic Analysis of the Hematopoietic System between Human and Mouse by Single Cell RNA Sequencing.

Authors:  Shouguo Gao; Zhijie Wu; Jeerthi Kannan; Liza Mathews; Xingmin Feng; Sachiko Kajigaya; Neal S Young
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

4.  HoxA9 binds and represses the Cebpa +8 kb enhancer.

Authors:  Lei Peng; Hong Guo; Peilin Ma; Yuqing Sun; Lauren Dennison; Peter D Aplan; Jay L Hess; Alan D Friedman
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 5.  From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases.

Authors:  Jennifer Enciso; Rosana Pelayo; Carlos Villarreal
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

6.  EBF1 primes B-lymphoid enhancers and limits the myeloid bias in murine multipotent progenitors.

Authors:  Iwo Kucinski; Ward Deboutte; Marta Derecka; Aurelie Lenaerts; Pierre Cauchy; Thomas Manke; Berthold Göttgens; Rudolf Grosschedl
Journal:  J Exp Med       Date:  2022-09-01       Impact factor: 17.579

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.